{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:07:57Z","timestamp":1787998077039,"version":"build-2784847793"},"reference-count":52,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,26]],"date-time":"2027-05-26T00:00:00Z","timestamp":1811289600000},"content-version":"am","delay-in-days":390,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jacc.2026.01.076","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T14:10:17Z","timestamp":1773843017000},"page":"2785-2803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Combining Genomics With Lipid and Inflammatory Biomarkers to Predict Coronary Artery Disease Risk"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5391-3776","authenticated-orcid":false,"given":"Raysha","family":"Farah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Seo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buu","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Mi Jemma","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1135-9647","authenticated-orcid":false,"given":"Sarah Margaret","family":"Urbut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniruddh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1249-4522","authenticated-orcid":false,"given":"Paul M.","family":"Ridker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akl C.","family":"Fahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.jacc.2026.01.076_bib1","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1161\/CIRCULATIONAHA.121.057125","article-title":"The American Heart Association's focus on primordial prevention","volume":"144","author":"Lloyd-Jones","year":"2021","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.jacc.2026.01.076_bib2","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa2405182","article-title":"Inflammation, cholesterol, lipoprotein(a), and 30-year cardiovascular outcomes in women","volume":"391","author":"Ridker","year":"2024","journal-title":"N Engl J Med"},{"issue":"39","key":"10.1016\/j.jacc.2026.01.076_bib3","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1093\/eurheartj\/ehaf209","article-title":"Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk study","volume":"46","author":"Kraaijenhof","year":"2025","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jacc.2026.01.076_bib4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCRESAHA.116.310527","article-title":"How common is residual inflammatory risk?","volume":"120","author":"Ridker","year":"2017","journal-title":"Circ Res"},{"issue":"2A","key":"10.1016\/j.jacc.2026.01.076_bib5","doi-asserted-by":"crossref","first-page":"33A","DOI":"10.1016\/j.amjcard.2005.11.014","article-title":"Justification for the use of statins in primary prevention: an intervention trial evaluating rosuvastatin (JUPITER)\u2014can C-reactive protein be used to target statin therapy in primary prevention?","volume":"97","author":"Mora","year":"2006","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.jacc.2026.01.076_bib6","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.jacc.2026.01.076_bib7","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.jacc.2026.01.076_bib8","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"issue":"8 Suppl","key":"10.1016\/j.jacc.2026.01.076_bib9","doi-asserted-by":"crossref","first-page":"C19","DOI":"10.1016\/j.jacc.2005.10.066","article-title":"C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients","volume":"47","author":"Tsimikas","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.jacc.2026.01.076_bib10","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1038\/s41591-025-04083-x","article-title":"Eleven clinical trials that will shape medicine in 2026","volume":"31","author":"May","year":"2025","journal-title":"Nat Med"},{"issue":"39","key":"10.1016\/j.jacc.2026.01.076_bib11","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacc.2026.01.076_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.jacc.2026.01.076_bib13","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1016\/j.jacc.2018.06.082","article-title":"Clinician's guide to reducing inflammation to reduce atherothrombotic risk: JACC Review Topic of the Week","volume":"72","author":"Ridker","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"44","key":"10.1016\/j.jacc.2026.01.076_bib14","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1093\/eurheartj\/ehae565","article-title":"Universal screening for hsCRP in patients with atherosclerotic disease: a major therapeutic opportunity","volume":"45","author":"Liuzzo","year":"2024","journal-title":"Eur Heart J"},{"issue":"44","key":"10.1016\/j.jacc.2026.01.076_bib15","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1093\/eurheartj\/ehae557","article-title":"Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease","volume":"45","author":"Mazhar","year":"2024","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacc.2026.01.076_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.123.066213","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among 13 970 contemporary high-risk patients with statin intolerance","volume":"149","author":"Ridker","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacc.2026.01.076_bib17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jamacardio.2022.4466","article-title":"Predictive utility of a coronary artery disease polygenic risk score in primary prevention","volume":"8","author":"Marston","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"7","key":"10.1016\/j.jacc.2026.01.076_bib18","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41591-023-02429-x","article-title":"A multi-ancestry polygenic risk score improves risk prediction for coronary artery disease","volume":"29","author":"Patel","year":"2023","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.jacc.2026.01.076_bib19","first-page":"e93","article-title":"Polygenic risk scores for cardiovascular disease: a scientific statement from the American Heart Association","volume":"146","author":"O'Sullivan","year":"2022","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacc.2026.01.076_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.124.004937","article-title":"Importance of clinical, laboratory, and genetic risk factors for incident CAD","volume":"18","author":"Bhattacharya","year":"2025","journal-title":"Circ Genom Precis Med"},{"issue":"16","key":"10.1016\/j.jacc.2026.01.076_bib21","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.jacc.2018.07.079","article-title":"Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention","volume":"72","author":"Inouye","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"43","key":"10.1016\/j.jacc.2026.01.076_bib22","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1093\/eurheartj\/ehw450","article-title":"Genomic prediction of coronary heart disease","volume":"37","author":"Abraham","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.jacc.2026.01.076_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nrg1805","article-title":"Genetic susceptibility to coronary artery disease: from promise to progress","volume":"7","author":"Watkins","year":"2006","journal-title":"Nat Rev Genet"},{"issue":"6","key":"10.1016\/j.jacc.2026.01.076_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrg.2016.160","article-title":"Genetics of coronary artery disease: discovery, biology and clinical translation","volume":"18","author":"Khera","year":"2017","journal-title":"Nat Rev Genet"},{"issue":"2","key":"10.1016\/j.jacc.2026.01.076_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003304","article-title":"Integrated polygenic tool substantially enhances coronary artery disease prediction","volume":"14","author":"Riveros-Mckay","year":"2021","journal-title":"Circ Genom Precis Med"},{"issue":"11","key":"10.1016\/j.jacc.2026.01.076_bib26","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1161\/ATVBAHA.120.314856","article-title":"Genome-wide polygenic score, clinical risk factors, and long-term trajectories of coronary artery disease","volume":"40","author":"Hindy","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.jacc.2026.01.076_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.124.004681","article-title":"Dynamic importance of genomic and clinical risk for coronary artery disease over the life course","volume":"18","author":"Urbut","year":"2025","journal-title":"Circ Genom Precis Med"},{"issue":"9","key":"10.1016\/j.jacc.2026.01.076_bib28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jacc.2026.01.076_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160461","article-title":"A survey of U.S. adults' opinions about conduct of a nationwide Precision Medicine Initiative(R) cohort study of genes and environment","volume":"11","author":"Kaufman","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jacc.2026.01.076_bib30","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/jamainternmed.2018.2875","article-title":"Evaluation of the pooled cohort risk equations for cardiovascular risk prediction in a multiethnic cohort from the Women's Health Initiative","volume":"178","author":"Mora","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1016\/j.jacc.2026.01.076_bib31","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.amjcard.2016.11.042","article-title":"Evaluation of the pooled cohort equations for prediction of cardiovascular risk in a contemporary prospective cohort","volume":"119","author":"Emdin","year":"2017","journal-title":"Am J Cardiol"},{"issue":"7726","key":"10.1016\/j.jacc.2026.01.076_bib32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"issue":"25 Pt B","key":"10.1016\/j.jacc.2026.01.076_bib33","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.jacc.2026.01.076_bib34","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jacc.2019.03.009","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jacc.2026.01.076_bib35","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.jacc.2026.01.076_bib36","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jacc.2016.10.018","article-title":"Estimating longitudinal risks and benefits from cardiovascular preventive therapies among Medicare patients: the Million Hearts Longitudinal ASCVD Risk Assessment Tool. A special report from the American Heart Association and American College of Cardiology","volume":"69","author":"Lloyd-Jones","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.jacc.2026.01.076_bib37","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.034946","article-title":"Using sex-specific polygenic risk to prognosticate coronary artery disease in women","volume":"13","author":"Paruchuri","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.jacc.2026.01.076_bib38","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.121.003542","article-title":"Sex-specific survival bias and interaction modeling in coronary artery disease risk prediction","volume":"16","author":"Surakka","year":"2023","journal-title":"Circ Genom Precis Med"},{"issue":"6509","key":"10.1016\/j.jacc.2026.01.076_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba3066","article-title":"The impact of sex on gene expression across human tissues","volume":"369","author":"Oliva","year":"2020","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jacc.2026.01.076_bib40","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamacardio.2019.5954","article-title":"Association of monogenic vs polygenic hypercholesterolemia with risk of atherosclerotic cardiovascular disease","volume":"5","author":"Trinder","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.jacc.2026.01.076_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003106","article-title":"Polygenic risk score for low-density lipoprotein cholesterol is associated with risk of ischemic heart disease and enriches for individuals with familial hypercholesterolemia","volume":"14","author":"Wu","year":"2021","journal-title":"Circ Genom Precis Med"},{"issue":"10","key":"10.1016\/j.jacc.2026.01.076_bib42","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41569-024-01039-5","article-title":"The LDL cumulative exposure hypothesis: evidence and practical applications","volume":"21","author":"Ference","year":"2024","journal-title":"Nat Rev Cardiol"},{"issue":"22","key":"10.1016\/j.jacc.2026.01.076_bib43","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.jacc.2026.01.076_bib44","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/s41588-022-01233-6","article-title":"Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants","volume":"54","author":"Aragam","year":"2022","journal-title":"Nat Genet"},{"issue":"24","key":"10.1016\/j.jacc.2026.01.076_bib45","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa1605086","article-title":"Genetic risk, adherence to a healthy lifestyle, and coronary disease","volume":"375","author":"Khera","year":"2016","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jacc.2026.01.076_bib46","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1161\/CIRCULATIONAHA.119.043805","article-title":"Predicting benefit from evolocumab therapy in patients with atherosclerotic disease using a genetic risk score: results from the FOURIER trial","volume":"141","author":"Marston","year":"2020","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.jacc.2026.01.076_bib47","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/CIRCULATIONAHA.116.024436","article-title":"Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting","volume":"135","author":"Natarajan","year":"2017","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.jacc.2026.01.076_bib48","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1001\/jama.2024.21957","article-title":"Zerlasiran\u2014a small-interfering RNA targeting lipoprotein(a): a phase 2 randomized clinical trial","volume":"332","author":"Nissen","year":"2024","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.jacc.2026.01.076_bib49","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJMoa2211023","article-title":"Small interfering RNA to reduce lipoprotein(a) in cardiovascular disease","volume":"387","author":"O'Donoghue","year":"2022","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.jacc.2026.01.076_bib50","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.jacc.2026.01.076_bib51","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1001\/jama.2023.21835","article-title":"Lepodisiran, an extended-duration short interfering RNA targeting lipoprotein(a): a randomized dose-ascending clinical trial","volume":"330","author":"Nissen","year":"2023","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jacc.2026.01.076_bib52","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population","volume":"186","author":"Fry","year":"2017","journal-title":"Am J Epidemiol"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109726003281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109726003281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:27:26Z","timestamp":1784680046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109726003281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":52,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0735109726003281"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2026.01.076","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combining Genomics With Lipid and Inflammatory Biomarkers to Predict Coronary Artery Disease Risk","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2026.01.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}